In silico screening of SARS-CoV2 helicase using African natural products: Docking and molecular dynamics approaches
Description
In the current medical era, there is an urgent necessity to identify new effective drugs to enrich the COVID-19's therapeutic arsenal. The SARS-COV-2 NSP13/helicase enzyme has been identified as a potential target for developing novel COVID-19